NDC product
RotaTeq
NDC 0006-4379 · Merck Sharp & Dohme LLC
Key facts
| Product NDC | 0006-4379 |
|---|---|
| Proprietary name | RotaTeq |
| Nonproprietary name | Rotavirus Vaccine, Live, Oral, Pentavalent |
| Substances | HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN, HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN, HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN, HUMAN ROTAVIRUS A TYPE G4P7(5) STRAIN BRB LIVE ANTIGEN, HUMAN ROTAVIRUS A TYPE G6P1A(8) STRAIN WI79 LIVE ANTIGEN |
| Dosage form | SOLUTION |
| Route | ORAL |
| Labeler | Merck Sharp & Dohme LLC |
| Product type | VACCINE |
| Marketing category | BLA |
| Application number | BLA125122 |
| Pharmacologic classes | Actively Acquired Immunity [PE], Live Rotavirus Vaccine [EPC], Rotavirus Vaccines [CS], Vaccines, Live, Unattenuated [CS] |
| Marketing start | May 15, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: